Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

Author： Lems W.   Lodder M.   Lips P.   Bijlsma J.   Geusens P.   Schrameijer N.   Ven C.   Dijkmans B.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.17, Iss.5, 2006-05, pp. : 716-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial

By Bhattoa H.   Bettembuk P.   Balogh A.   Szegedi G.   Kiss E.  

Osteoporosis International, Vol. 15, Iss. 5, 2004-05 ,pp. : 396-404

Springer Publishing Company

Access to resources Recommend Favorite

Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1703-1710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of omega 3 fatty acids plus low‐dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo‐controlled study

By  

JOURNAL OF PERIODONTAL RESEARCH, Vol. 50, Iss. 6, 2015-12 ,pp. : 721-729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2570-2579

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

By Rhee Y.   Kang M.   Min Y.   Byun D.   Chung Y.   Ahn C.   Baek K.   Mok J.   Kim* D.   Kim** D.   Kim H.   Kim Y.   Myoung S.   Kim*** D.   Lim S.-K.  

Osteoporosis International, Vol. 17, Iss. 12, 2006-12 ,pp. : 1801-1807

Springer Publishing Company

Access to resources Recommend Favorite